Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

被引：0
|
作者：
Meghan E. Jones
Jeffrey S. Andrews
Douglas E. Faries
John Landry
Jenny Xu
Holland C. Detke
Rashna Chhabra-Khanna
David P. McDonnell
机构：
[1] Eli Lilly and Company,
[2] Eli Lilly Canada,undefined
[3] Inc.,undefined
[4] MacroStat (China) Clinical Research Co.,undefined
[5] Ltd.,undefined
[6] Lilly UK,undefined
[7] Eli Lilly and Company,undefined
来源：
BMC Psychiatry | / 15卷
关键词：
Olanzapine; Long-acting injection; Schizophrenia; Antipsychotics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
    Angela L Hill
    Bin Sun
    Jamie L Karagianis
    Susan B Watson
    David P McDonnell
    BMC Psychiatry, 11
  • [42] Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
    Hill, Angela L.
    Sun, Bin
    Karagianis, Jamie L.
    Watson, Susan B.
    McDonnell, David P.
    BMC PSYCHIATRY, 2011, 11
  • [43] INTERIM ANALYSIS OF OVERALL SURVIVAL PER SUBGROUPS IN THE PROSPECTIVE, NON-INTERVENTIONAL INSIGHT STUDY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Ganten, T.
    Schott, E.
    Galle, P.
    Goehler, T.
    Malfertheiner, P.
    Stauber, R.
    Buder, R.
    Achilles, K.
    Gerken, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 255 - 256
  • [44] Interim analysis of overall survival per subgroups in the prospective, non-interventional INSIGHT study in patients with hepatocellular carcinoma treated with Sorafenib
    Malfertheiner, P.
    Ganten, T. M.
    Schott, E.
    Galle, P. R.
    Goehler, T.
    Stauber, R.
    Buder, R.
    Achilles, K.
    Gerken, G.
    ONKOLOGIE, 2012, 35 : 162 - 162
  • [45] Updated interim analysis of PAVE: a prospective, non-interventional study in Germany of ruxolitinib (RUX) in patients (Pts) with polycythaemia vera (PV)
    Griesshammer, M.
    Von der Heyde, E.
    Schlag, R.
    Schmidt, B.
    Weniger, S.
    Koenigsmann, M.
    Stauch, M.
    Baum, V.
    Weide, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 267 - 267
  • [46] PERFUSE: A FRENCH PROSPECTIVE/RETROSPECTIVE NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAIIVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; AN INTERIM ANALYSIS
    Fautrel, B.
    Bouhnik, Y.
    Desjeux, G.
    Brigui, A.
    Freudensprung, U.
    Addison, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 293 - 294
  • [47] Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study
    Borek, D. M.
    Smith, R. C.
    Gruber, C. N.
    Gruber, B. L.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (07) : 1455 - 1464
  • [48] PERFUSE: A French Prospective/Retrospective Non-interventional Cohort Study of Infliximab-naive and Transitioned Patients Receiving Infliximab Biosimilar SB2; An Interim Analysis
    Fautrel, Bruno
    Bouhnik, Yoram
    Desjeux, Guillaume
    Freudensprung, Ulrich
    Addison, Janet
    Brigui, Amira
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study
    D.M. Borek
    R.C. Smith
    C.N. Gruber
    B.L. Gruber
    Osteoporosis International, 2019, 30 : 1455 - 1464
  • [50] Comparison of hospitalization risk before and after changing from risperidone long-acting injection to another long-acting injection or oral antipsychotic in patients with schizophrenia: Mirror-image study
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    Inoue, Yuichi
    Takaya, Atsuhiko
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2016, 70 (08) : 365 - 366
12345